SPYRE THERAPEUTICS, INC. (SYRE) Operating margin 2016–2023
SPYRE THERAPEUTICS, INC. (SYRE) operating margin by fiscal year — reported operating income divided by reported revenue.
-27348.0%FY2023 · since FY2016: -473.3% → -27348.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -27348.0% | -23707.7 pp |
| FY2022 | -3640.2% | -3289.9 pp |
| FY2021 | -350.3% | — |
| FY2018 | -1169.3% | -637.6 pp |
| FY2017 | -531.7% | -58.4 pp |
| FY2016 | -473.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SYRE financial trends
SYRE RevenueSYRE Net incomeSYRE Net marginSYRE Gross profitSYRE Gross marginSYRE Operating incomeSYRE Operating cash flowSYRE Free cash flowSYRE Capital expendituresSYRE Return on equitySYRE Stock buybacksSYRE Dividends paidSYRE Total assetsSYRE Total liabilitiesSYRE Shareholders’ equitySYRE overview →